The researchers and physicians used electronic health records to identify conditions associated with cardiovascular disease. They then combined the EHR records with a probabilistic graphical network, an AI program, to calculate how many of those conditions would lead a patient to become at-risk for heart disease, heart transplants or sinoatrial node dysfunction.
The study found that the most at-risk adults had a medical history of cardiomyopathy, viral myocarditis or using the heart failure drug milrinone.
Patients who had a combination of these were at greater risk, according to the study.
The researchers said they believe this technology has the potential to help physicians treat, prevent or even foresee if a patient might be at-risk for heart conditions.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
